Menu
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
      • Cardiac T2* with FerriScan
      • Iron Overload
      • Iron Overload in Cancer Survivors
      • Easy Setup for Radiology Centres
        • MRI Scanner Details Form
      • FerriScan Information for Clinicians
      • FerriScan: Patient Management Guidelines
      • FerriScan Information for Patients
    • HepaFat-Scan - MRI Measurement of Liver Fat
      • Fatty Liver Disease
      • Easy Setup for Radiology Centres
        • MRI Scanner Details Form
      • HepaFat-Scan Information for Clinicians
      • HepaFat-Scan Information for Patients
    • Bone Marrow R2-MRI
    • Quality Assured Service Delivery
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
    • R&D
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
  • Fast Login
  • Easy Setup
  • Find a Centre
  • Radiology Survey
  • Home
  • About
    • Board and Management Team
    • Quality Assured Service Delivery
    • Contact Us
  • Products
    • FerriScan - MRI Measurement of Liver Iron Concentration
      • Cardiac T2* with FerriScan
      • Iron Overload
      • Iron Overload in Cancer Survivors
      • Easy Setup for Radiology Centres
        • MRI Scanner Details Form
      • FerriScan Information for Clinicians
      • FerriScan: Patient Management Guidelines
      • FerriScan Information for Patients
    • HepaFat-Scan - MRI Measurement of Liver Fat
      • Fatty Liver Disease
      • Easy Setup for Radiology Centres
        • MRI Scanner Details Form
      • HepaFat-Scan Information for Clinicians
      • HepaFat-Scan Information for Patients
    • Bone Marrow R2-MRI
    • Quality Assured Service Delivery
  • Resources
  • Reimbursement
  • Clinical Trial Services
  • Investors
    • Business Overview
    • Board and Management Team
    • Share Price
    • ASX Announcements
      • 2018
      • 2017
      • 2016
      • 2015
      • 2014
      • 2013
      • 2012
      • 2011
      • 2010
      • 2009
      • 2008
      • 2007
      • 2006
      • 2005
      • 2004
    • ASX subscribe
    • Annual Reports
    • Analyst Coverage
    • R&D
  • News
    • Latest News
    • News Subscribe
    • Events
  • Contact
Home | Investors | ASX Announcements | 2009

ASX Announcements 2009

Date Document
24/12/2009 Change of Director`s Interest Notice
24/12/2009 Appendix 3B
25/11/2009 Results of Annual General Meeting
25/11/2009 AGM Presentation to Shareholders
09/11/2009 Additional FerriScan Revenue and International Presentations
30/10/2009 Appendix 4C - quarterly
27/10/2009 Annual Report 2009
27/10/2009 Notice of Annual General Meeting
05/10/2009 Initial Director`s Interest Notice
05/10/2009 Board Appointment of Simon Panton
30/09/2009 Resonance Health announces FerriScan Rapide
21/09/2009 2009 Financial Report
28/08/2009 Preliminary Final Report
21/08/2009 Investor Update
28/07/2009 Appendix 4C - quarterly
29/06/2009 Change of Director`s Interest Notice
29/06/2009 Change of Director`s Interest Notice
29/04/2009 Appendix 4C - quarterly
27/02/2009 Half Yearly Report and Accounts
27/02/2009 RHT announces 5th consecutive profitable quarter
16/02/2009 Initial Director`s Interest Notice
16/02/2009 Appointment of Director
28/01/2009 Appendix 4C - quarterly

 

Investors

  • Business Overview
  • Board and Management Team
  • Share Price
  • ASX Announcements
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
  • ASX subscribe
  • Annual Reports
  • Analyst Coverage
  • R&D
  • Twitter
  • LinkedIn
  • Search
  • © 2018 Resonance Health
  • Disclaimer
  • Privacy
  • Sitemap
Website by Dash Digital